Neurogene (NGNE) Stock Chart & Stock Price History $28.92 +3.09 (+11.96%) As of 11:10 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Neurogene Stock Price Performance The Neurogene (NGNE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 41.63%, with a year-to-date return of 26.51%. In the past month, the stock has increased 50.23%, reflecting recent market activity. As of the latest close, Neurogene traded at $25.83 with a market cap of $368.59 million and volume of 291,477 shares. Receive NGNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurogene and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+29.45%1 Month Performance+50.23%3 Month Performance+36.03%Year-To-Date Performance+26.51%1 Year Performance-41.63% NGNE Stock Chart for Thursday, October, 9, 2025 NGNE Chart by TradingView Neurogene Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/08/2025$23.47$25.83+10.06%$28.00$23.10291,477 shs$368.59 million10/07/2025$23.09$23.47+1.65%$24.40$22.02350,754 shs$334.92 million10/06/2025$22.34$23.09+3.36%$24.30$21.86307,243 shs$329.54 million10/03/2025$20.98$22.34+6.48%$24.50$20.00466,560 shs$318.84 million10/02/2025$17.98$20.98+16.69%$21.41$17.76507,550 shs$299.39 million10/01/2025$17.33$17.98+3.75%$18.48$17.29101,096 shs$256.58 million09/30/2025$17.71$17.33-2.15%$18.06$17.18128,329 shs$247.33 million09/29/2025$17.82$17.71-0.62%$18.15$17.51138,324 shs$252.72 million09/26/2025$17.41$17.82+2.35%$18.13$17.24117,549 shs$254.29 million09/25/2025$17.25$17.41+0.93%$17.45$16.85127,774 shs$248.44 million Get the Latest News and Ratings for NGNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurogene and its competitors with MarketBeat's FREE daily newsletter. 09/24/2025$16.85$17.25+2.37%$17.53$16.94128,311 shs$246.19 million09/23/2025$16.98$16.85-0.77%$17.51$16.77151,677 shs$240.45 million09/22/2025$17.20$16.98-1.28%$17.93$16.95221,381 shs$242.31 million09/19/2025$18.68$17.20-7.92%$18.68$17.00215,456 shs$245.44 million09/18/2025$17.71$18.68+5.48%$18.94$17.64131,605 shs$266.56 million09/17/2025$17.44$17.71+1.55%$18.40$17.55111,371 shs$252.72 million09/16/2025$17.45$17.44-0.06%$18.30$17.13188,988 shs$248.87 million09/15/2025$19.00$17.45-8.16%$19.52$17.4397,415 shs$249.01 million09/12/2025$20.08$19.00-5.38%$20.42$18.77123,016 shs$271.13 million09/11/2025$18.60$20.08+7.96%$20.72$18.62829,800 shs$265.46 million09/10/2025$19.25$18.60-3.38%$19.63$18.3796,244 shs$265.42 million09/09/2025$19.45$19.25-1.03%$19.79$18.7355,912 shs$274.70 million09/08/2025$19.95$19.45-2.51%$20.01$18.84103,379 shs$277.59 million Related Companies ZYME Stock Price Chart NUVB Stock Price Chart ARDX Stock Price Chart AMPH Stock Price Chart TRML Stock Price Chart PHVS Stock Price Chart ATAI Stock Price Chart CVAC Stock Price Chart TRVI Stock Price Chart AMLX Stock Price Chart Receive NGNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurogene and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NGNE) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
